Selectivity of action of pregabalin on Ca(2+) channels but not on fusion pore, exocytotic machinery, or mitochondria in chromaffin cells of the adrenal gland.

Standard

Selectivity of action of pregabalin on Ca(2+) channels but not on fusion pore, exocytotic machinery, or mitochondria in chromaffin cells of the adrenal gland. / Hernández-Vivanco, Alicia; Perez-Alvarez, Alberto; Caba-González, José Carlos; Alonso, María Teresa; Moreno-Ortega, Ana José; Cano-Abad, María; Ruiz-Nuño, Ana; Carmona-Hidalgo, Beatriz; Albillos, Almudena.

in: J PHARMACOL EXP THER, Jahrgang 342, Nr. 2, 2, 2012, S. 263-272.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Hernández-Vivanco, A, Perez-Alvarez, A, Caba-González, JC, Alonso, MT, Moreno-Ortega, AJ, Cano-Abad, M, Ruiz-Nuño, A, Carmona-Hidalgo, B & Albillos, A 2012, 'Selectivity of action of pregabalin on Ca(2+) channels but not on fusion pore, exocytotic machinery, or mitochondria in chromaffin cells of the adrenal gland.', J PHARMACOL EXP THER, Jg. 342, Nr. 2, 2, S. 263-272. <http://www.ncbi.nlm.nih.gov/pubmed/22537772?dopt=Citation>

APA

Hernández-Vivanco, A., Perez-Alvarez, A., Caba-González, J. C., Alonso, M. T., Moreno-Ortega, A. J., Cano-Abad, M., Ruiz-Nuño, A., Carmona-Hidalgo, B., & Albillos, A. (2012). Selectivity of action of pregabalin on Ca(2+) channels but not on fusion pore, exocytotic machinery, or mitochondria in chromaffin cells of the adrenal gland. J PHARMACOL EXP THER, 342(2), 263-272. [2]. http://www.ncbi.nlm.nih.gov/pubmed/22537772?dopt=Citation

Vancouver

Hernández-Vivanco A, Perez-Alvarez A, Caba-González JC, Alonso MT, Moreno-Ortega AJ, Cano-Abad M et al. Selectivity of action of pregabalin on Ca(2+) channels but not on fusion pore, exocytotic machinery, or mitochondria in chromaffin cells of the adrenal gland. J PHARMACOL EXP THER. 2012;342(2):263-272. 2.

Bibtex

@article{d4691a9138db4c4194e34b114a7c5f9b,
title = "Selectivity of action of pregabalin on Ca(2+) channels but not on fusion pore, exocytotic machinery, or mitochondria in chromaffin cells of the adrenal gland.",
abstract = "The present study was planned to investigate the action of pregabalin on voltage-dependent Ca(2+) channels (VDCCs) and novel targets (fusion pore formed between the secretory vesicle and the plasma membrane, exocytotic machinery, and mitochondria) that would further explain its inhibitory action on neurotransmitter release. Electrophysiological recordings in the perforated-patch configuration of the patch-clamp technique revealed that pregabalin inhibits by 33.4 ± 2.4 and 39 ± 4%, respectively, the Ca(2+) current charge density and exocytosis evoked by depolarizing pulses in mouse chromaffin cells. Approximately half of the inhibitory action of pregabalin was rescued by l-isoleucine, showing the involvement of ?2?-dependent and -independent mechanisms. Ca(2+) channel blockers were used to inhibit Cav1, Cav2.1, and Cav2.2 channels in mouse chromaffin cells, which were unselectively blocked by the drug. Similar values of Ca(2+) current charge blockade were obtained when pregabalin was tested in human or bovine chromaffin cells, which express very different percentages of VDCC types with respect to mouse chromaffin cells. These results demonstrate that the inhibitory action of pregabalin on VDCCs and exocytosis does not depend on ?1 Ca(2+) channel subunit types. Carbon fiber amperometric recordings of digitonin-permeabilized cells showed that neither the fusion pore nor the exocytotic machinery were targeted by pregabalin. Mitochondrial Ca(2+) measurements performed with mitochondrial ratiometric pericam demonstrated that Ca(2+) uptake or release from mitochondria were not affected by the drug. The selectivity of action of pregabalin might explain its safety, good tolerability, and reduced adverse effects. In addition, the inhibition of the exocytotic process in chromaffin cells might have relevant clinical consequences.",
keywords = "Animals, Humans, Mice, Cattle, Calcium/metabolism, Calcium Channel Blockers/pharmacology, Adrenal Glands/*drug effects/metabolism, Calcium Channels/*metabolism, Chromaffin Cells/*drug effects/*metabolism, Exocytosis/*drug effects, Isoleucine/pharmacology, Membrane Potentials/drug effects, Mitochondria/*drug effects/metabolism, Neurotransmitter Agents/metabolism, gamma-Aminobutyric Acid/*analogs & derivatives/pharmacology, Animals, Humans, Mice, Cattle, Calcium/metabolism, Calcium Channel Blockers/pharmacology, Adrenal Glands/*drug effects/metabolism, Calcium Channels/*metabolism, Chromaffin Cells/*drug effects/*metabolism, Exocytosis/*drug effects, Isoleucine/pharmacology, Membrane Potentials/drug effects, Mitochondria/*drug effects/metabolism, Neurotransmitter Agents/metabolism, gamma-Aminobutyric Acid/*analogs & derivatives/pharmacology",
author = "Alicia Hern{\'a}ndez-Vivanco and Alberto Perez-Alvarez and Caba-Gonz{\'a}lez, {Jos{\'e} Carlos} and Alonso, {Mar{\'i}a Teresa} and Moreno-Ortega, {Ana Jos{\'e}} and Mar{\'i}a Cano-Abad and Ana Ruiz-Nu{\~n}o and Beatriz Carmona-Hidalgo and Almudena Albillos",
year = "2012",
language = "English",
volume = "342",
pages = "263--272",
journal = "J PHARMACOL EXP THER",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "2",

}

RIS

TY - JOUR

T1 - Selectivity of action of pregabalin on Ca(2+) channels but not on fusion pore, exocytotic machinery, or mitochondria in chromaffin cells of the adrenal gland.

AU - Hernández-Vivanco, Alicia

AU - Perez-Alvarez, Alberto

AU - Caba-González, José Carlos

AU - Alonso, María Teresa

AU - Moreno-Ortega, Ana José

AU - Cano-Abad, María

AU - Ruiz-Nuño, Ana

AU - Carmona-Hidalgo, Beatriz

AU - Albillos, Almudena

PY - 2012

Y1 - 2012

N2 - The present study was planned to investigate the action of pregabalin on voltage-dependent Ca(2+) channels (VDCCs) and novel targets (fusion pore formed between the secretory vesicle and the plasma membrane, exocytotic machinery, and mitochondria) that would further explain its inhibitory action on neurotransmitter release. Electrophysiological recordings in the perforated-patch configuration of the patch-clamp technique revealed that pregabalin inhibits by 33.4 ± 2.4 and 39 ± 4%, respectively, the Ca(2+) current charge density and exocytosis evoked by depolarizing pulses in mouse chromaffin cells. Approximately half of the inhibitory action of pregabalin was rescued by l-isoleucine, showing the involvement of ?2?-dependent and -independent mechanisms. Ca(2+) channel blockers were used to inhibit Cav1, Cav2.1, and Cav2.2 channels in mouse chromaffin cells, which were unselectively blocked by the drug. Similar values of Ca(2+) current charge blockade were obtained when pregabalin was tested in human or bovine chromaffin cells, which express very different percentages of VDCC types with respect to mouse chromaffin cells. These results demonstrate that the inhibitory action of pregabalin on VDCCs and exocytosis does not depend on ?1 Ca(2+) channel subunit types. Carbon fiber amperometric recordings of digitonin-permeabilized cells showed that neither the fusion pore nor the exocytotic machinery were targeted by pregabalin. Mitochondrial Ca(2+) measurements performed with mitochondrial ratiometric pericam demonstrated that Ca(2+) uptake or release from mitochondria were not affected by the drug. The selectivity of action of pregabalin might explain its safety, good tolerability, and reduced adverse effects. In addition, the inhibition of the exocytotic process in chromaffin cells might have relevant clinical consequences.

AB - The present study was planned to investigate the action of pregabalin on voltage-dependent Ca(2+) channels (VDCCs) and novel targets (fusion pore formed between the secretory vesicle and the plasma membrane, exocytotic machinery, and mitochondria) that would further explain its inhibitory action on neurotransmitter release. Electrophysiological recordings in the perforated-patch configuration of the patch-clamp technique revealed that pregabalin inhibits by 33.4 ± 2.4 and 39 ± 4%, respectively, the Ca(2+) current charge density and exocytosis evoked by depolarizing pulses in mouse chromaffin cells. Approximately half of the inhibitory action of pregabalin was rescued by l-isoleucine, showing the involvement of ?2?-dependent and -independent mechanisms. Ca(2+) channel blockers were used to inhibit Cav1, Cav2.1, and Cav2.2 channels in mouse chromaffin cells, which were unselectively blocked by the drug. Similar values of Ca(2+) current charge blockade were obtained when pregabalin was tested in human or bovine chromaffin cells, which express very different percentages of VDCC types with respect to mouse chromaffin cells. These results demonstrate that the inhibitory action of pregabalin on VDCCs and exocytosis does not depend on ?1 Ca(2+) channel subunit types. Carbon fiber amperometric recordings of digitonin-permeabilized cells showed that neither the fusion pore nor the exocytotic machinery were targeted by pregabalin. Mitochondrial Ca(2+) measurements performed with mitochondrial ratiometric pericam demonstrated that Ca(2+) uptake or release from mitochondria were not affected by the drug. The selectivity of action of pregabalin might explain its safety, good tolerability, and reduced adverse effects. In addition, the inhibition of the exocytotic process in chromaffin cells might have relevant clinical consequences.

KW - Animals

KW - Humans

KW - Mice

KW - Cattle

KW - Calcium/metabolism

KW - Calcium Channel Blockers/pharmacology

KW - Adrenal Glands/drug effects/metabolism

KW - Calcium Channels/metabolism

KW - Chromaffin Cells/drug effects/metabolism

KW - Exocytosis/drug effects

KW - Isoleucine/pharmacology

KW - Membrane Potentials/drug effects

KW - Mitochondria/drug effects/metabolism

KW - Neurotransmitter Agents/metabolism

KW - gamma-Aminobutyric Acid/analogs & derivatives/pharmacology

KW - Animals

KW - Humans

KW - Mice

KW - Cattle

KW - Calcium/metabolism

KW - Calcium Channel Blockers/pharmacology

KW - Adrenal Glands/drug effects/metabolism

KW - Calcium Channels/metabolism

KW - Chromaffin Cells/drug effects/metabolism

KW - Exocytosis/drug effects

KW - Isoleucine/pharmacology

KW - Membrane Potentials/drug effects

KW - Mitochondria/drug effects/metabolism

KW - Neurotransmitter Agents/metabolism

KW - gamma-Aminobutyric Acid/analogs & derivatives/pharmacology

M3 - SCORING: Journal article

VL - 342

SP - 263

EP - 272

JO - J PHARMACOL EXP THER

JF - J PHARMACOL EXP THER

SN - 0022-3565

IS - 2

M1 - 2

ER -